Skip to main content
. 2020 Sep 26;10(10):1370. doi: 10.3390/biom10101370

Figure 3.

Figure 3

Therapeutic approaches targeting glutamate-glutamine metabolism in malignant gliomas. Summarization of some putative targets and drugs (red) in glioma cells: inhibition of glutaminase (GLS); inhibition of glutamine synthetase (GS); xc inhibition; GLT-1 overexpression; GLAST silencing. White arrows represent the transporters’ expression level in gliomas: down arrow corresponds to lower expression; up arrow is overexpression.